Renaissance Technologies’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.1K | Buy |
133,464
+96,518
| +261% | +$65.9K | ﹤0.01% | 3316 |
|
|
2025
Q1 | $33.7K | Buy |
+36,946
| New | +$33.7K | ﹤0.01% | 3327 |
|
|
2024
Q2 | – | Sell |
-274,033
| Closed | -$518K | – | 3565 |
|
|
2024
Q1 | $518K | Buy |
274,033
+186,833
| +214% | +$353K | ﹤0.01% | 2850 |
|
|
2023
Q4 | $230K | Buy |
87,200
+27,400
| +46% | +$72.3K | ﹤0.01% | 3084 |
|
|
2023
Q3 | $138K | Sell |
59,800
-95,200
| -61% | -$220K | ﹤0.01% | 3176 |
|
|
2023
Q2 | $566K | Buy |
155,000
+103,900
| +203% | +$379K | ﹤0.01% | 2808 |
|
|
2023
Q1 | $182K | Sell |
51,100
-90,600
| -64% | -$323K | ﹤0.01% | 3314 |
|
|
2022
Q4 | $404K | Sell |
141,700
-284,447
| -67% | -$811K | ﹤0.01% | 3069 |
|
|
2022
Q3 | $950K | Sell |
426,147
-153,553
| -26% | -$342K | ﹤0.01% | 2529 |
|
|
2022
Q2 | $1.44M | Buy |
579,700
+60,400
| +12% | +$150K | ﹤0.01% | 2441 |
|
|
2022
Q1 | $2.53M | Buy |
519,300
+414,700
| +396% | +$2.02M | ﹤0.01% | 2050 |
|
|
2021
Q4 | $1.18M | Buy |
+104,600
| New | +$1.18M | ﹤0.01% | 2518 |
|
|
2021
Q1 | – | Sell |
-68,300
| Closed | -$854K | – | 3374 |
|
|
2020
Q4 | $854K | Sell |
68,300
-55,196
| -45% | -$690K | ﹤0.01% | 2580 |
|
|
2020
Q3 | $1.86M | Buy |
123,496
+22,496
| +22% | +$339K | ﹤0.01% | 2180 |
|
|
2020
Q2 | $2.48M | Buy |
101,000
+20,607
| +26% | +$505K | ﹤0.01% | 2070 |
|
|
2020
Q1 | $1.14M | Buy |
80,393
+37,000
| +85% | +$525K | ﹤0.01% | 2363 |
|
|
2019
Q4 | $689K | Buy |
+43,393
| New | +$689K | ﹤0.01% | 2782 |
|